Combination therapy with glutaminase inhibitors and immuno-oncology agents

The invention relates to methods of treating cancer, myeloproliferative diseases, or immunological or neurological diseases with a combination of a glutaminase inhibitor and an immuno-oncology therapeutic agent, such as an inhibitor of arginase, CTLA-4, indoleamine 2,3-dioxygenase, and/or PD-1/PD-L1...

Full description

Saved in:
Bibliographic Details
Main Authors Bennett, Mark K, Bromley, Susan D, Parlati, Francesco, Molineaux, Susan M, Gross, Matthew I
Format Patent
LanguageEnglish
Published 09.03.2021
Subjects
Online AccessGet full text

Cover

Loading…